|
November 2022
Overall, there is not enough scientific evidence to show that any dietary supplement can help manage or prevent type 2 diabetes. Some dietary supplements may provide some benefit for some conditions associated with type 2 diabetes. It is important to note, however, that there are multiple case reports linking dietary supplement use to kidney disease, which is of particular concern because diabetes is the leading cause of chronic kidney disease and kidney failure in the United States. Supplement use should be monitored closely in patients who have or are at risk for kidney disease.
This issue of the digest addresses some of the many supplements studied for diabetes—such as alpha-lipoic acid, chromium, magnesium, and omega-3s—with a focus on those that have undergone clinical trials.
Read more »
Learn what current research has to say about:
Read more »
Visit NCCIH’s website to read the full issue of this month’s Clinical Digest.
NCCIH Clinical Digest is a service of the National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health (NIH), U.S. Department of Health and Human Services. NCCIH Clinical Digest, a monthly e-newsletter, offers evidence-based information on complementary and integrative health, including scientific literature searches, summaries of NCCIH-funded research, fact sheets for patients, and more.
NCCIH is 1 of 27 institutes and centers at the NIH. The mission of NCCIH is to define, through rigorous scientific investigation, the usefulness and safety of complementary and alternative medicine interventions and their roles in improving health and health care. For additional information, call NCCIH’s Clearinghouse toll free at 1-888-644-6226, or visit the NCCIH website at nccih.nih.gov.
|
